阅读说明：本技术 Acalabrutinib的新晶型及其制备方法和用途 (Novel crystal form of Acaraburtinib and preparation method and application thereof ) 是由 陈敏华 张炎锋 刘远 张龙 杨朝惠 于 2019-03-05 设计创作，主要内容包括：本发明涉及Acalabrutinib的新晶型及其制备方法,含有该晶型的药物组合物,以及该晶型在制备布鲁顿酪氨酸激酶抑制剂和治疗套细胞淋巴癌药物制剂中的用途。本发明提供的Acalabrutinib晶型比现有技术具有一种或多种改进的特性,对未来该药物的优化和开发具有重要价值。<Image he="553" wi="700" file="DDA0002268949770000011.GIF" imgContent="drawing" imgFormat="GIF" orientation="portrait" inline="no"></Image>(The invention relates to a novel crystal form of Acalabrutinib, a preparation method thereof, a pharmaceutical composition containing the crystal form, and application of the crystal form in preparation of Bruton tyrosine kinase inhibitors and pharmaceutical preparations for treating mantle cell lymphoma. Compared with the prior art, the Acalabastinib crystal form provided by the invention has one or more improved characteristics, and has important value for the optimization and development of the medicine in the future.)